Mabion
  • Company
    • About us
      • History
      • Leaderships
      • Team
      • EU grants
      • Requests for Proposal
      • Sustainability – ESG
      • Bussines strategy
      • Quality policy
      • Virtual Tour
    • Investors
      • Corporate documents
      • Shareholders and shares
      • Periodic reports
      • Current reports
      • Sustainability reports
      • Corporate governance at Mabion
      • Financial data
      • For Investors
      • Calendar
  • Resources
    • Science Hub
    • Press releases
    • News
    • Events
    • Media kit
  • Services
    • Process Development
    • Analytics 
    • Drug Substance Manufacturing
  • Contact
    • Contact form
    • Contact for investors
    • Contact for media
    • Careers
  • Science News
  • Resources

GMP

scaling up biologics production

Scaling up Biologics Production at Mabion with Single-use Bioreactors and Automated Monitoring 

Biologics, Drug development, GMP, Mabion, Manufacturing
tech transfer CDMO

Understanding the Role of Tech Transfer CDMOs in Biologics Manufacturing

Analytics, Biologics, GMP, Manufacturing, Regulatory
Robust scale down models for reliable bioprocess scale up

Robust Scale-down Model for Reliable Upstream Bioprocessing Scale-up

Drug substance, GMP, Mabion, Manufacturing
biosimilars regulatory requirements in global markets

Biosimilars Regulatory Requirements in Global Markets

Biosimilars, EMA, FDA, GMP, Regulatory
GMP cell banking process

GMP Cell Banking as a Foundation of Safe Biologics Manufacturing

Biologics, Cell banking, GMP, Manufacturing
Preparing for Regulatory Audits with Reliable Quality Systems at Mabion

Preparing for Regulatory Audits at Mabion with Reliable Quality Systems

Biologics, EMA, FDA, GMP, Mabion, Regulatory
Meeting global regulatory standards in biologic drug manufacturing projects in Mabion Biologics

Meeting Global Regulatory Standards in Biologic Drug Manufacturing Projects

Biologics, EMA, FDA, GMP, Mabion, Manufacturing, Regulatory
cell line development

Tailoring Cell Line Development for Efficient Biologics Process Outcomes

Biologics, Drug development, GMP, Manufacturing
gmp biologics manufacturing

GMP Biologics Manufacturing in End-to-End Drug Development

Biologics, Drug development, GMP, Manufacturing
1 2 Next

Contact

Find out how we may support your business.

bd@mabion.eu

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

    Mabion
    • Privacy policy
    • CDMO
    • Media kit
    • Press releases
    • Events

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. HTML Sitemap

    Powered by

    Veneo